ERCC1 expression and activity of PELF regimen as first-line treatment of metastatic gastric cancer patients.

e14603 Background: The role of the excision repair cross-complementing 1 (ERCC1) is well documented in a large number of tumor types with cisplatin-based chemotherapy. The aim of this study was to ...